NCT03948269

Brief Summary

Background: Menopause syndrome generally occurs with and is related to psychological problems. However, Internet- and mobile-based group treatment (imGT) may improve women's physiological and psychological conditions. Objective: To investigate the efficacy of group treatment with or without Internet- and mobile-based treatment of menopause, mood swings and quality of life status. Methods: This protocol is for a randomized controlled clinical trial with a sample of 144 menopausal women divided into 2 groups: imGT and face-to-face group treatment (ffGT). The primary outcome will be the menopausal symptom improvement of the two groups, as assessed by Greene Climacteric Scale. The secondary outcomes will be quality of life, assessed by the Short Form 36 Health Survey Questionnaire; insomnia, assessed by the Pittsburgh Sleep Quality Inventory; anxiety, assessed by the Hamilton Anxiety Rating Scale; and therapeutic alliance, assessed by the Working Alliance Inventory-Short Revised. imGT will be performed once a week for 1.5 hours for 10 weeks with a daily Punched-in on the WeChat App; ffGT will be performed once a week for 1.5 hours for 10 weeks. All outcomes will be assessed at baseline, at a post-intervention evaluation (week 10), and at a follow-up evaluation (week 22). Discussion: This study will be the first clinical trial to examine the effects of imGT on menopausal women in China. If imGT is found to be equivalent to or superior to ffGT, it will facilitate easier access to menopausal health services, which may be feasible to offer to other medical institution.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2018

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

May 9, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 13, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2020

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2020

Completed
Last Updated

May 14, 2019

Status Verified

May 1, 2019

Enrollment Period

1.8 years

First QC Date

May 9, 2019

Last Update Submit

May 10, 2019

Conditions

Keywords

menopausegroup treatmentmood swingquality of life

Outcome Measures

Primary Outcomes (3)

  • Greene Climacteric Scale

    Greene Climacteric Scale is used for evaluating menopausal symptoms. It contains 21 questions covering 5 domains: anxiety, depression, somatic symptoms, vasomotor symptoms, and sexual function. Each question is answered on a 4-point Likert scale. The answers to all 21 questions are summed to give a total quality-of-life measure; a higher score indicates a worse quality of life. According to the hypothesis and PRO-specific domains of this trial, vasomotor symptoms, anxiety and depression will be analysed specifically. The Chinese version of this questionnaire has a high validation (0.90), and the Cronbach's alpha coefficient is 0.95, while its test-retest reliability is 0.94 (P \<0.01).

    week 0

  • Greene Climacteric Scale

    Menopause symptoms after 10 sessions of group cognitive behavioral therapy

    week 10

  • Greene Climacteric Scale

    Menopause symptoms of one follow-up meeting

    week 22

Secondary Outcomes (12)

  • The Short Form 36 Health Survey Questionnaire

    week 0

  • The Short Form 36 Health Survey Questionnaire

    week 10

  • The Short Form 36 Health Survey Questionnaire

    week 22

  • Pittsburgh Sleep Quality Index

    week 0

  • Pittsburgh Sleep Quality Index

    week 10

  • +7 more secondary outcomes

Study Arms (2)

Internet- and mobile-based group treatment

EXPERIMENTAL

the therapy consists of 10 modules (15 hours in total) in groups of 8 participants each over a period of 10 weeks and one follow-up meeting (2 hours) 12 weeks after the 10th module (week 22). Each module is adapted from the previous literature on CBT rationale and will be conducted online on WeChat, a mobile social networking software with 1 billion users in 2018. First, we will establish a WeChat group containing the imGT group members and psychiatrists, in which everyone can talk instantly. The interactive treatments will be conducted every Friday evening for a duration of 1.5 hours via text, audio or video messaging.

Behavioral: group behavioral cognitive therapy

Face-to-face group treatment

ACTIVE COMPARATOR

10 modules will be conducted every weekend in the psychological counseling room of The Affiliated Obstetrics and Gynaecology Hospital of Nanjing Medical University.

Behavioral: group behavioral cognitive therapy

Interventions

First, we will establish a WeChat group containing the imGT group members and psychiatrists, in which everyone can talk instantly. The interactive treatments will be conducted every Friday evening for a duration of 1.5 hours via text, audio or video messaging. Table 1 summarizes the module topics and provides detailed information on the treatment program. All modules will be saved for repeated viewing after completion. Second, we will establish another WeChat program named Punched-in which participants report on aspects of their everyday life such as diet, sports, readings or mood, according to the plan made by psychiatrists, via text, audio, photo or video message. This program will only be visible to and able to be commented on by participants and psychiatrists.

Face-to-face group treatmentInternet- and mobile-based group treatment

Eligibility Criteria

Age40 Years - 60 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • aged 40\~60, in menopausal transition or post-menopause, according to the STRAW +10 definition
  • have Internet access
  • have mobile phone access
  • have sufficient knowledge of the Chinese language
  • have scored in the clinical range for menopause syndrome from the psychiatric interview
  • have signed a consent form that will be provided to eligible participants.

You may not qualify if:

  • not completing informed consent
  • presence of any of the following diseases: hyperthyroidism, coronary atherosclerotic heart disease, hypertension (BP≥140/90 mmHg), pheochromocytoma, neurasthenia, psychosis, or other diseases closely related to the main disease
  • troublesome drinking
  • drug use (hypnotics or hormone therapy) in the past 14 days, which might affect mood.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

the Affiliated Obstetrics and Gynaecology Hospital of Nanjing Medical University

Nanjing, Jiangsu, 210000, China

Location

Study Officials

  • Jing Ms Kong, Master

    the Affiliated Obstetrics and Gynaecology Hospital of Nanjing Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Mixed-effects models (random intercept) with interaction effects of group and time will be conducted on primary and secondary repeating outcomes.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

May 9, 2019

First Posted

May 13, 2019

Study Start

June 1, 2018

Primary Completion

March 31, 2020

Study Completion

August 31, 2020

Last Updated

May 14, 2019

Record last verified: 2019-05

Locations